Pharmexcil working to boost exports to Africa

Source: The Hindu Business Line, Apr 27, 2017

Hyderabad: The Pharmaceutical Export Promotion Council (Pharmexcil) is working jointly with the Centre for harmonisation of export norms with African countries.

This was disclosed by its Chairman M Madan Mohan Reddy at a press conference, after the inauguration of the 5th edition of pharma expo, IPHEX 2017, here on Thursday.

Harmonisation of regulations will help pharma exporters by way of providing automatic approvals, among others.

Read the rest of this entry »

Govt’s generic push will dent Rs 90,000-cr branded pharma market

Source: Business Standard, Apr 24, 2017

New Delhi / Mumbai: Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now.

Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a public event on Monday. The health ministry has now started working on amending the Drugs and Cosmetics Act to this effect.“Indian patients may face quality issues without price benefit as intense competition among marketers will lead to incentivising a chemist,” says D G Shah, secretary-general of the Indian Pharmaceutical Alliance.

Read the rest of this entry »

Growth in Indian pharma exports revives in the third quarter

Source: Business Standard, Feb 27, 2017

Hyderabad: Indian pharma exports have increased 5.6 per cent to $4,357 million during October-December period in this financial year over the same quarter previous fiscal, as per the Pharmaceuticalsa Export Promotion Council (Pharmexcil) data.

The pharma body, which works under the Union Commerce Ministry, expects the rise in exports in the second half of this year to more than compensate for a marginal decline in the exports during April-October period. Read the rest of this entry »

Cadila, Cipla step up investments for improved drug quality

download.jpgSource: Business Standard, Feb 24, 2017

Mumbai: Drug makers including Cadila Healthcare and Cipla are investing in automation to enhance quality compliance and monitor deviations in manufacturing processes.

Investment in automation is one of the step undertaken by Indian companies who have come under the scanner of overseas drug regulators. Violations in good manufacturing practices have resulted in warning letters and delayed product approvals for Indian companies. To overcome this pharma companies are investing in both technology and staff training.

“We have invested around Rs 450 crore in automation and technology improvements. We have introduced laboratory information management system and a software which tracks deviations in manufacturing. We have also implemented electronic batch records system in our new plants in Ahmedabad SEZ and Vadodara and will be rolling out the electronic system in all other plants in next few years,” said Sharvil Patel, deputy managing director of Cadila Healthcare.

Read the rest of this entry »

Agility opens storage facility for pharma products at Hyderabad airport

Source: Business Standard, Feb 03, 2017

Hyderabad: Global logistics provider Agility has set up the first temperature-controlled life sciences storage and handling facility at the international airport in Hyderabad.

According to the company, the storage centre, spread across an area of 6,000 square feet, is strategically placed to serve pharmaceutical manufacturers in Hyderabad, Goa, Pune, Visakhapatnam and Bengaluru, the company said.The centre will operate as the primary warehouse for solutions from va-Q-tec, an advanced passive packaging company specialising in high-end, secured cold chain products.

“Life sciences is one of the cornerstones of the Indian economy with exports expected to grow an astonishing 60 per cent in 2017. The new centre will help fast-growing Indian life sciences companies to meet the rising global demand for their products,” said Detley Janik, CEO, Agility South Asia.

Agility is one of the largest freight forwarders and logistics providers in India. It operates from 61 locations and controls 1.5 lakh square meters of warehouse space covering all major ports, airports and inland locations in the country.

Aurobindo Pharma buys Generis in a bid to boost margins in Europe

Source:, Jan 09, 2017

Aurobindo Pharma Ltd wanted an acquisition that could lift the profitability of its European operations; its earnings before interest, taxes, depreciation and amortization (Ebitda) margin was in the mid-single digits, compared with the company’s overall 24.6% (in the September quarter).Its acquisition of Portugal’s Generis Farmaceutica SA is a step in that direction, with the target firm’s estimated margin at 19.6% in 2016, pegged to increase to 21.9% in 2017.

The real benefit of this acquisition can be attained if Aurobindo can drive up its scale of operations and use synergies to lower costs.

Read the rest of this entry »

Specialty drugs to remain focus of pharma deals in 2017

Source:, Dec 29, 2016

Mumbai: A few years ago, Indian companies made acquisitions to expand manufacturing capabilities and increase their portfolio of generic drugs, which are copycat versions of branded medicines.However, in the past couple of years, the emphasis has shifted to buying companies, assets or products in the specialty, complex generics or branded space as these acquisitions have the potential for much higher returns.

“Big Indian pharma companies are giving more and more focus on developed markets and specialty portfolios. That trend is going to continue next year as they look to strengthen their business. The US will remain the key market for such acquisitions,” said Amit Mookim, general manager, South Asia, QuintilesIMS, a healthcare research and services company.

Read the rest of this entry »